Skip to main content

Table 1 Baseline clinical and biochemical characteristics of 7067 Chinese Type 2 diabetic patients with no past history of coronary heart disease (CHD)

From: Impacts of chronic kidney disease and albuminuria on associations between coronary heart disease and its traditional risk factors in type 2 diabetic patients – the Hong Kong diabetes registry

  Development of CHD before the censoring date  
No (n = 6716) Yes (n = 351)  
median or % IQR median or % IQR P value
Follow-up time (years) 5.58 2.97–7.89 2.77 1.48–5.28 <0.001
Male 45.0% / 51.9% / 0.012†
Smoking status:
Current smoker 20.1% / 29.1% / 0.057†
Ex smoker 13.2% / 18.2% /  
Age (years) 56 46–67 64 54–70 <0.001‡
Sex adjusted waist circumference (cm)* 55.9 0.16 61.9 0.72 <0.001‡
Body mass index (kg/m2) 24.7 22.4–27.3 24.6 22.7–26.7 0.748‡
Known duration of diabetes (year) 5 1–10 9 4–14 <0.001‡
Systolic blood pressure (mmHg) 134 121–148 141 130–155 <0.001‡
Diastolic blood pressure (mmHg) 76 69–83 78 70–85 <0.001‡
Peripheral arterial disease 5.4% / 13.7% / <0.001†
Retinopathy 25.6% / 42.5% / <0.001†
Sensory neuropathy 25.5% / 32.2% / 0.005†
Glycated haemoglobin (%) 7.3 6.4–8.6 7.6 6.6–9.3 <0.001‡
Blood haemoglobin (g/L) 13.8 12.8–14.9 13.6 12.4–14.7 0.019‡
Spot urinary ACR (mg/mmol) 1.88 0.75–9.81 7.65 1.61–72.3 <0.001‡
Increased albuminuria (ACR ≥3.5 mg/mmol in female & ≥2.5 mg/mmol.in male) 41.2% / 64.9% / <0.001‡
eGFR (ml/min/1.73 m2) 105.8 84.9–127.5 89.8 66.0–112.9 <0.001‡
eGFR <60 ml/min/1.73 m2 9.3% / 18.5% / <0.001
Low-density lipoprotein cholesterol (mmol/l) 3.10 2.50–3.80 3.52 2.9–4.2 <0.001‡
High-density lipoprotein cholesterol (mmol/l) 1.25 1.05–1.50 1.14 0.99–1.37 <0.001‡
Triglyceride (mmol/L) 1.37 0.96–2.06 1.55 1.11–2.18 <0.001‡
Total cholesterol (mmol/L) 5.20 4.50–5.90 5.54 4.85–6.30 <0.001†
Baseline use of drugs:
Oral anti-diabetic drugs 60.9% / 59.0% / 0.448†
Anti-hypertensive drugs 33.2% / 43.0% / <0.001†
Insulin 17.0% / 25.9% / <0.001†
Lipid lowering drugs 12.3% / 13.7% / 0.450†
ACEI or ARB 20.0% / 25.1% / 0.022†
  1. IQR, inter-quartile range; eGFR, estimated glomerular filtration rate; ACEI, Angiotensin-converting enzyme inhibitors; ARB, angiotensin II receptor blockers; ACR, albumin:creatinie ratio; *, derived from analysis of covariance; †, derived from Chi-square text; ‡, derived from Wilcoxon two-sample test.